X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2580) 2580
Book Review (724) 724
Publication (314) 314
Magazine Article (18) 18
Book Chapter (8) 8
Conference Proceeding (5) 5
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1875) 1875
humans (1726) 1726
tenofovir disoproxil fumarate (1438) 1438
tenofovir (1026) 1026
female (883) 883
infectious diseases (878) 878
male (810) 810
hiv infections - drug therapy (808) 808
hiv (695) 695
adult (665) 665
disoproxil fumarate (655) 655
pharmacology & pharmacy (619) 619
adenine - analogs & derivatives (591) 591
middle aged (498) 498
immunology (489) 489
anti-hiv agents - therapeutic use (488) 488
human immunodeficiency virus--hiv (443) 443
emtricitabine (437) 437
gastroenterology & hepatology (419) 419
hepatitis b (403) 403
virology (392) 392
antiviral agents - therapeutic use (389) 389
antiviral agents (388) 388
lamivudine (385) 385
antiretroviral therapy (381) 381
treatment outcome (374) 374
hepatitis b, chronic - drug therapy (369) 369
anti-hiv agents - administration & dosage (347) 347
drug therapy (341) 341
adenine - therapeutic use (317) 317
anti-hiv agents - adverse effects (314) 314
aids/hiv (302) 302
therapy (299) 299
antiretroviral drugs (298) 298
hiv infection (288) 288
safety (287) 287
hiv infections - prevention & control (281) 281
risk factors (281) 281
organophosphonates - therapeutic use (278) 278
double-blind (276) 276
human-immunodeficiency-virus (267) 267
drug combinations (263) 263
infection (261) 261
deoxycytidine - analogs & derivatives (260) 260
adefovir dipivoxil (252) 252
hepatitis (247) 247
health aspects (246) 246
microbiology (239) 239
viral load (239) 239
drug therapy, combination (236) 236
prevention (231) 231
pharmacokinetics (229) 229
hepatitis b virus (222) 222
entecavir (211) 211
adenine - adverse effects (205) 205
care and treatment (202) 202
hiv infections - complications (201) 201
hiv infections - virology (199) 199
efficacy (196) 196
young adult (194) 194
adenine - administration & dosage (191) 191
analysis (189) 189
hepatocellular-carcinoma (188) 188
highly active antiretroviral therapy (184) 184
hiv-1 - drug effects (184) 184
pregnancy (184) 184
animals (183) 183
hiv-infected patients (183) 183
virus diseases (183) 183
drug resistance, viral (182) 182
research (182) 182
organophosphonates - adverse effects (180) 180
dosage and administration (176) 176
medicine & public health (174) 174
tenofovir - therapeutic use (171) 171
efavirenz (169) 169
hepatitis b virus - drug effects (162) 162
adolescent (161) 161
drug resistance (157) 157
organophosphonates - administration & dosage (157) 157
aids (156) 156
chronic hepatitis b (155) 155
infections (155) 155
patients (155) 155
antiviral therapy (149) 149
active antiretroviral therapy (147) 147
deoxycytidine - therapeutic use (146) 146
clinical trials (145) 145
anti-hiv agents - pharmacokinetics (138) 138
acquired immune deficiency syndrome--aids (137) 137
resistance (137) 137
article (134) 134
lamivudine - therapeutic use (134) 134
hepatitis b virus - genetics (133) 133
interferon (131) 131
reverse transcriptase inhibitors - therapeutic use (131) 131
retrospective studies (130) 130
infected patients (128) 128
reverse-transcriptase inhibitors (128) 128
risk (127) 127
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2523) 2523
French (27) 27
German (20) 20
Spanish (14) 14
Korean (10) 10
Chinese (3) 3
Czech (2) 2
Polish (2) 2
Turkish (2) 2
Italian (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 05/2013, Volume 63, Issue 1, pp. 96 - 100
We report week 96 results from a phase 3 trial of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (EVG/COBI/FTC/TDF, n = 348) vs... 
HIV | cobicistat | phase 3 randomized trial | safety | efficacy | stribild | INFECTIOUS DISEASES | CO-FORMULATED ELVITEGRAVIR | NON-INFERIORITY TRIAL | PHASE-3 | IMMUNOLOGY | TREATMENT-NAIVE | EFAVIRENZ | LOPINAVIR/RITONAVIR | TENOFOVIR | RITONAVIR | Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | Humans | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | Male | RNA, Viral - blood | Thiazoles - administration & dosage | Carbamates - administration & dosage | Thiazoles - therapeutic use | Thiazoles - adverse effects | Young Adult | Deoxycytidine - therapeutic use | Adenine - adverse effects | HIV-1 - physiology | Quinolones - adverse effects | Adenine - therapeutic use | Quinolones - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Treatment Outcome | Adenine - administration & dosage | Oxazines - adverse effects | Organophosphonates - administration & dosage | Quinolones - administration & dosage | Oxazines - therapeutic use | Creatinine - blood | Carbamates - adverse effects | HIV Infections - drug therapy | Carbamates - therapeutic use | Deoxycytidine - analogs & derivatives | Drug Combinations | Clinical trials | Patient safety | Immunology | Comparative analysis | Drug therapy | Human immunodeficiency virus--HIV | Indexing in process | Index Medicus | AIDS/HIV
Journal Article
Basic & Clinical Pharmacology & Toxicology, ISSN 1742-7835, 04/2019, Volume 124, Issue 4, pp. 479 - 490
Journal Article
Journal Article
by Taramasso, L and Di Biagio, A and Maggiolo, F and Tavelli, A and Lo Caputo, S and Bonora, S and Zaccarelli, M and Caramello, P and Costantini, A and Viscoli, C and d'Arminio Monforte, A and Cozzi‐Lepri, A and Andreoni, M and Angarano, G and Antinori, A and Castelli, F and Cauda, R and Di Perri, G and Galli, M and Iardino, R and Ippolito, G and Lazzarin, A and Perno, C. F and Schloesser, F and Viale, P and Castagna, A and Ceccherini‐Silberstein, F and Girardi, E and Mussini, C and Puoti, M and Ammassari, A and Balotta, C and Bandera, A and Bonfanti, P and Borderi, M and Calcagno, A and Calza, L and Capobianchi, M. R and Cingolani, A and Cinque, P and De Luca, A and Gianotti, N and Gori, A and Guaraldi, G and Lapadula, G and Lichtner, M and Madeddu, G and Marchetti, G and Marcotullio, S and Monno, L and Nozza, S and Quiros Roldan, E and Rossotti, R and Rusconi, S and Santoro, M. M and Saracino, A and Fanti, I and Galli, L and Lorenzini, P and Rodano, A and Shanyinde, M and Carletti, F and Carrara, S and Di Caro, A and Graziano, S and Petrone, F and Prota, G and Quartu, S and Truffa, S and Giacometti, A and Valeriani, C and Santoro, C and Suardi, C and Donati, V and Verucchi, G and Minardi, C and Quirino, T and Abeli, C and Manconi, P. E and Piano, P and Cacopardo, B and Celesia, B and Vecchiet, J and Falasca, K and Sighinolfi, L and Segala, D and Mazzotta, F and Vichi, F and Cassola, G and Alessandrini, A and Bobbio, N and Mazzarello, G and Mastroianni, C and Belvisi, V and Caramma, I and Chiodera, A and Castelli, A. P and Rizzardini, G and Ridolfo, A. L and Piolini, R and ... and Italian Cohort Naive and Italian Cohort Naive Antiretrovirals (ICONA) Foundation Study Group and the Italian Cohort Naive Antiretrovirals (ICONA) Foundation Study Group
HIV Medicine, ISSN 1464-2662, 08/2018, Volume 19, Issue 7, pp. 475 - 484
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 11/2017, Volume 67, Issue 5, pp. 918 - 924
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 02/2019, Volume 844, pp. 139 - 144
Journal Article
Journal Article